垂体转移瘤:瑞典全国队列特征及乳腺癌重点分析
71%存在ACTH缺乏、65%存在TSH缺乏、26%存在尿崩症,18%初被误诊为垂体腺瘤。
要点
- 乳腺癌和肺癌是垂体转移瘤最常见原发来源。
- HER2过表达乳腺癌似更易发生垂体转移,且可在初诊多年后出现。
- 垂体转移可被误诊为垂体腺瘤,并常合并未诊断的垂体功能减退。
核心结论
- 垂体转移瘤可能被误诊为垂体腺瘤,尤其在乳腺癌患者中可迟发出现。
- HER2过表达的乳腺癌似易转移至垂体,低皮质醇血症可能被误判为肿瘤相关不适。
研究设计与样本
- 27例经组织病理学确诊,11例依据影像学(含快速进展)高度疑诊。
- 复核病历并集中重新阅片鞍区影像。
主要发现
- 原发肿瘤为乳腺癌者占45%,肺癌者占21%。
- 乳腺癌来源的垂体转移中53%在初诊原发肿瘤≥10年后出现。
- 起病时71%存在ACTH缺乏、65%存在TSH缺乏、26%存在尿崩症。
- 晨皮质醇<100 nmol/L者中47%报告乏力、恶心/呕吐、食欲减退、体重下降、肌痛和/或关节痛,而皮质醇≥200 nmol/L者为23%。
临床怎么用
- 对乳腺癌(尤其HER2过表达)或肺癌患者出现垂体占位或垂体功能减退时应警惕垂体转移。
- 对肿瘤患者出现乏力、恶心、食欲减退等非特异症状时应评估垂体功能,避免将低皮质醇血症误判为肿瘤相关不适。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the contemporary presentation of pituitary metastases. PATIENTS: Thirty-eight patients diagnosed with pituitary metastases from 1996 to 2018 in Sweden. METHODS: Pituitary metastases were confirmed by histopathology (n = 27) or considered highly likely according to radiological findings, including rapid tumor progression (n = 11). Medical records were reviewed and sellar images reexamined centrally. RESULTS: Breast and lung cancers were the most common primary tumors, in 45% and 21% of patients, respectively. Sixty-seven percent of breast cancers overexpressed human epidermal growth factor receptor 2 (HER2); 53% of pituitary metastases from breast cancers appeared ≥10 years after diagnosis of the primary tumor. At presentation, 71% appeared to have ACTH deficiency, 65% had TSH deficiency, and 26% had diabetes insipidus. Fatigue, nausea/vomiting, loss of appetite, weight loss, myalgia, and/or arthralgia were reported in 47% of patients with morning cortisol <100 nmol/L vs 23% with cortisol ≥200 nmol/L. Sixteen patients had visual field defects, and eight had diplopia. Intrasellar and suprasellar tumor growth was the most frequent finding. Initially, a pituitary adenoma was considered the etiology in 18% of patients.Radiotherapy, pituitary surgery, and chemotherapy were used in 68%, 68%, and 11% of patients, respectively. One and 2 years after diagnosis of pituitary metastases, 50% and 26% of patients were alive. CONCLUSION: Pituitary metastases may be mistaken for pituitary adenomas and can appear late, especially in breast cancer. Breast cancers overexpressing HER2 seem prone to metastasize to the pituitary. Hypocortisolism may be misdiagnosed as cancer-related malaise. An increased awareness of pituitary metastases and undiagnosed pituitary failure can improve management in these patients.
引用
- Schill F, Nilsson M, Olsson DS, et al. Pituitary Metastases: A Nationwide Study on Current Characteristics With Special Reference to Breast Cancer. J Clin Endocrinol Metab. 2019. PMID: 30892659. doi:10.1210/jc.2019-00012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。